Step-Edit Training Program

Size: px
Start display at page:

Download "Step-Edit Training Program"

Transcription

1 Step-Edit Training Program What are step-edit programs? Why are they important? How can you address them?

2 Step-edit programs affect your bottom line Step-edit programs create hassles for pharmacists, nursing staff, patients, and physicians. These hassles can influence the behavior of these stakeholders. And their behavior can ultimately reduce your market share and volume. Step-edit programs can lead to lower market share Step edits create hassles Hassles for physicians, pharmacists, nursing staff, and patients Hassles shape behavior Lead to pharmacy switches Generally shape physician prescribing habits Discourage patients from initiating therapy Changed b Changed behavior shapes growth potential changes market share Leads to lower market share and volume Did you know? Step edit: a drug benefit rule requiring patients to try a lower cost medication before the health plan or PBM will provide coverage for a higher cost medication. Step edits and prior authorization are both pharmacy benefit management techniques. Did you know? Prior authorization: a benefit rule requiring patients to receive approval from the health plan or PBM prior to receiving coverage for the service or medication being provided. Step edits are managed at the point of sale in the retail pharmacy Plans believe that step edits are effective and inexpensive to implement Step edits complement co-payment tiers as a cost-controlling mechanism Step edits typically require the use of inexpensive generic agents prior to the use of more expensive branded agents

3 What can you do about step-edit programs? You can address each stakeholder in the system. You can become an expert on the step-edit programs that affect your territory. Market Share and Volume You have responsibility for working with all parties in the system. Since you call on the physicians, nurses, and pharmacists, it s imperative that you understand the impact step-edit programs have on each of them and that you have the knowledge and skills to engage them in the process.

4 What you need to know and how to find it out In order to become an expert on the step-edit programs that affect your territory, you ll need to invest some time. But don t worry there are many people to help you along the way. What you need to know Here is what you need to know about the managed care organizations, health plans, Medicare plans, employers, and physician medical groups that affect your territory: Information Type 1. Formulary products 2. Specific step-edit language 3. Percent of business Example (TK) Must try and fail on ACEI before starting ARB 73% Use the chart at the end of this tool to help you keep track of this information. How to find it out You have a number of resources for information about the managed care environment in your territory. But the first person you should go to is your District Manager (DM). Resources that provide the information you need The Edge Regional Formulary Grid The Managed Care District Analysis Monthly Report Obstacle Handler Cards Analyzer Reports You District Manager Regional Account Manager (RAM) Regional Account Professional (RAP)

5 The pharmacy is the crucial link in the step-edit system. Patients can become discouraged and fail to follow up on treatment. A 2005 WellPoint study showed that 11% of patients who encountered a step edit in filling a prescription did not fill a prescription for any therapy for that condition in the following year. Your pharmacy calls are important. You can learn about how the real managed markets dynamics are impacting your business by talking to pharmacists. Did you know? A survey of pharmacists found that every pharmacist knew about step-edit programs and, yet, no pharmaceutical representative had ever talked to them about step edits. Did you know? Some physician offices have a specific phone line for pharmacists to leave a message about coverage issues. These messages are typically processed once a day usually in the afternoon (3:00 PM). If a pharmacist calls after the messages have been processed for the day, the patient will not get resolution of the issue until the following day. Be sure to keep track of these policies for the large physician offices in your territory, on your handheld and let the pharmacists you call on know about them.

6 Can we add some type here? how step edits work 1. Patient visits physician 2. Physician prescribes drug 3a. Patient presents prescription to pharmacist for fill This is the moment of truth the pharmacist has to act on the step edit Pharmacist calls physician s office to make change or appeal the step edit Pharmacist tells patient drug is not covered unless the step edit is followed first 3b. If the plan has implemented a step edit for a drug, the pharmacist is alerted. Typically, the alert is as simple as a pop-up screen describing the particular step edit 3c. Pharmacist checks prescription for coverage with health plan or PBM through networked computer $ 4. Nursing staff is the first point of contact for pharmacists Some offices have a reimbursement specialist for these calls Nursing staff pulls chart for physician 6. Pharmacist fills prescription 5. Physician reviews prescription Physician makes necessary changes or initiates appeal process 7. Patient receives drug

7 7

8 The hassle factor Patients Step edits create hassles Create inconvenience at the point of service Patient may have to wait, come back to the pharmacy, or go back to see the physician Hassles shape behavior Patient avoids healthcare system Changed b Changed behavior shapes growth potential changes market share Leads to increased likelihood of discontinuing treatment or never initiating treatment at all Did you know? Many step edits cannot be resolved quickly. Patients who have to wait a long time for resolution may not start therapy at all!

9 Pharmacists Step edits create hassles Pharmacists dislike having to call the physician and the subsequent documentation required to override the step edit Most retail pharmacy chains will not allow a pharmacist to override a step edit without written documentation from the physician s office Increase pharmacists workload with calls or faxes to providers Hassles shape behavior Stop the process of dispensing medication for patients Reduce pharmacists ability to deliver optimal customer service Patients must wait longer for approval or come back to the pharmacy Patients may need to go back to their physician for a new prescription Create tension between the pharmacist and the patient Patients must pay full price for the brand Patients may feel they are receiving suboptimal treatment Patients are unable to begin treatment in a timely manner Changed b Changed behavior shapes growth potential changes market share Leads to physician changing prescription Leads to increased likelihood of discontinuing treatment or never initiating treatment at all Did you know? The profit margin for pharmacists on generics are usually greater than those of branded agents. Therefore, the incentive to push branded agents may not exist.

10 The hassle factor (cont d) Nursing Staff Step edits create hassles Require additional administrative functions Interrupt daily activities while tending to in-office patients Hassles shape behavior Nurses attention may be pulled away from in-office patients Many physician groups have nurses dedicated to reimbursement issues Changed b Changed behavior shapes growth potential changes market share Physicians avoid prescribing medications that are subject to step- edit programs Approaches for managing reimbursement issues may create patient hassles 10

11 Physicians Step edits create hassles Physicians dislike calls from pharmacies and the subsequent documentation required to override the step edit Physicians are not reimbursed for time spent dealing with step edits Place a burden on nursing staff and/or administrative teams Create potential ill will among patients due to confusion Hassles shape behavior Change desired treatment protocol for patient Changed b Changed behavior shapes growth potential changes market share Increases likelihood of discontinuing treatment or never initiating treatment at all You can help pharmacists, nurses, and physicians with step-edit programs Step-edit programs can significantly impact your market share by reducing the number of prescriptions actually filled at retail pharmacies However, you can help the pharmacists, nurses, and physicians you call on by providing relevant information 11

12 How to address the effect of step-edit programs in your territory This section will help you adapt your message to step-edit objections. There are 5 different approaches you can take when a pharmacist, physician, or member of the nursing staff brings up an objection based on step edits. The 5 step-edit approaches 1. Clinical value approaches: use the objection as an opportunity to show the superiority of product 2. Tolerability: discuss the tolerability of ARBs or RASILEZ as it relates to patient compliance with therapy 3. Low patient impact: many patients are not affected by step-edit programs; if this is the situation in your territory, encourage physicians to avoid making blanket changes in their prescribing based on step edits; be sure to quantify the impact of step-edit programs on the physicians you call on 4. Negative patient impact: some patients are negatively affected; the information you gather can help ease the process for all involved 5. Get specific: use your knowledge of the plan specifics to serve as a resource for pharmacists, physicians, and nursing staff Did you know? The Edge is a valuable tool for helping you communicate concern and understanding of the physician s point of view, prepare to ask meaningful questions, and creatively gain access. Use it to gather all the step-edit information you need as part of your precall planning. 12

13 Selected Novartis Success Principles for Performance Frontier Selling Creates Call Continuity Plan precall by using notes to build the call continuum Relationship Focused Invests in a business-relevant relationship; actively seeks common ground Communicates concern and understanding for physician s point of view Purposefully Probes and Listens Asks meaningful questions (eg, regarding patient types and treatment paths) Adapts Message Responds to physician s concerns, goals, or priorities Direct in Closing Ends with a direct call to action Has the Will to Win Creatively gains access Coordinates With Teammates Takes lead with all Novartis resources Works directly with copromotion partners 13

14 How to address the effect of step-edit programs in your territory (cont d) Pharmacists 1. Objection: Lack of authority to override the step edit must call the doctor or health plan Strategy: Acknowledge that these calls require nonproductive work time and make it difficult for pharmacists to do their job. Since different health plans have different requirements, pharmacists may find it difficult to keep up with all of them. Be prepared: Educational opportunity. Research the largest health plans in your territory to determine what information each requires of physicians in order to have the prescription filled. Talk to your DM, who will manage discussions with the RAM. Also, ask you customers what the step edit looks like what are they required to do. Intervention: Tools: Get specific discuss plan requirements with pharmacists so that they can consult with the physician Clinical value communicate the clinical significance of helping the patient get on the medication that the physician prescribed WellPoint reprint and discussion of the negative impact of step edits 2. Objection: The hassle factor Strategy: Acknowledge that these calls require a tremendous amount of time and energy and make it difficult for pharmacists to do their job. Explain the clinical significance of helping the patient get on the medication that the physician prescribed. You can also probe for information about the specific communication problem. Intervention: Get specific discuss plan requirements with pharmacists so that they can consult with the physician Clinical value communicate the clinical significance of helping the patient get on the medication that the physician prescribed 14

15 3. Objection: Customers blame me for step edits Strategy: Acknowledge that patients are typically unaware of what step edits are and why they may have been implemented. Explain that patients are at risk of not getting treatment because of the step edit. Probe for ways to help the pharmacist work with patients to get step edits resolved. Also acknowledge that step edits exist because health plans are trying to minimize the cost of therapy. Always redirect back to the clinical discussion. Intervention: Tools: Get specific encourage pharmacists to begin a dialogue with their customers and use this as an opportunity to educate customers about what their options might be: 1. Pay full price in order to begin treatment right away with what the doctor has prescribed.. Return to the doctor s office and get an alternative prescription.. Wait until the pharmacist receives an answer from the doctor s office. Clinical value communicate the clinical significance of helping the patient get on the medication that the physician prescribed Bramley reprint demonstrating improved compliance on ARBs vs other RAS agents and competitive categories P H A R M A C I S T S 4. Objection: My patients are happy with generics (Pharmacists have incentives to promote generics.) Strategy: Acknowledge that generics are a valuable option. Explain the improved compliance with ARBs. You can also point to value-added programs such as the BP Success Zone that improve compliance. Patients that are compliant with medications are also a benefit for pharmacists. Intervention: Clinical value communicate the clinical proven value of your product. Highlight any value-added programs. 15 R E S O U R C E S

16 How to address the effect of step-edit programs in your territory (cont d) Physicians Addressing step edits with a physician can be a double-edged sword. You may be introducing an objection that the physician didn t previously have. Discuss with your DM when a proactive approach is appropriate. 1. Objection: Hassle factor follow-up calls due to step edits Strategy: Acknowledge the burden of these calls and follow-up activities. Use the HEOR reprints to validate the clinical significance of helping a patient resolve a step edit. Be prepared: Research the largest health plans in your territory. Find out what they ask physicians to do to get the prescription filled. This information is available from your RAM. Communicate this information to the physician. Intervention: Tools: Clinical value talk about the clinical importance and benefits of your product Low patient impact explain that many patients are not affected by step edits Negative patient impact explain how patients may delay or not even start therapy when they encounter a step edit Get specific look for ways to help the nursing staff meet step-edit challenges WellPoint reprint demonstrating patients lost to therapy Bramley reprint demonstrating improved compliance on ARBs vs other RAS agents and competitive categories 16

17 2. Objection: No step edits with generics Strategy: Redirect the conversation to the clinical benefits of your product. Intervention: Clinical value present supporting evidence for your product. Use the Bramley reprint to show the tolerability and compliance of ARBs 3. Objection: Tier 3 objection Strategy: Know the plans in your territory that are affected by step edits or tier 3 status. If it is small, encourage the physician to focus on the majority of patients. Look for ways to help nursing staff handle the minority of patients affected by step edits. Redirect discussion back to clinical value. Intervention: Low patient impact help physicians understand that the majority of their patients are probably not affected by step edits Get specific for those who are affected, leverage Novartis co-payment offset programs Clinical value return discussion to clinical benefits of your product P H Y S I C I A N S 17

18 How to address the effect of step-edit programs in your territory (cont d) Nurses 1. Objection: Hassle factor frustration with administrative hassles or lack of time or personnel to handle step edits Strategy: Take time to acknowledge the burden that these calls and follow-up activities place upon physicians and their staff. This step helps build rapport with the nurse. Also, explain the risks to the patient of a step edit. Probe for ways to help the nurse with administrative tasks. And redirect the discussion to the negative clinical impact of step edits. Intervention: Remember: Get specific find out the step-edit procedures of your largest prescribers in the area. Communicate this information to nurses. Redirect discussion to clinical value Some physician offices have a specific phone line for pharmacists to leave a message about coverage issues. These messages are typically processed once a day usually in the afternoon (3:00 PM) Some physician offices have a specific reimbursement specialist to handle these calls Be sure to keep track of these policies for the large physician offices in your territory and let the pharmacists you call on know about them. 18

19 19 N U R S E S

20 How to address the effect of step-edit programs in your territory (cont d) How to fill out this guide Work with your DM and use the Product Analyzer Tool to identify the top plans in your territory with step edit programs 2. Get the information needed for those plans through the Managed Care District Analysis Monthly report Territory Step-Edit Guide Use this guide to keep track of all the relevant step-edit information for the plans that affect your territory. 1. Product: Plan/PBM name: Formulary Products: Specific step-edit language: Percent of business: 2. Product: Plan/PBM name: Formulary Products: Specific step-edit language: Percent of business: 3. Product: Plan/PBM name: Formulary Products: Specific step-edit language: Percent of business:

21 4. Product: Plan/PBM name: Formulary Products: Specific step-edit language: Percent of business: 5. Product: Plan/PBM name: Formulary Products: Specific step-edit language: Percent of business: 6. Product: Plan/PBM name: Formulary Products: Specific step-edit language: Percent of business: 21 R E S O U R C E S

22 How to address the effect of step-edit programs in your territory (cont d) Territory Step-Edit Guide Use this guide to keep track of all the relevant step-edit information for the plans that affect your territory. 1. Product: Plan/PBM name: Formulary Products: Specific step-edit language: Percent of business: 2. Product: Plan/PBM name: Formulary Products: Specific step-edit language: Percent of business: 3. Product: Plan/PBM name: Formulary Products: Specific step-edit language: Percent of business: 22

23 4. Product: Plan/PBM name: Formulary Products: Specific step-edit language: Percent of business: 5. Product: Plan/PBM name: Formulary Products: Specific step-edit language: Percent of business: 6. Product: Plan/PBM name: Formulary Products: Specific step-edit language: Percent of business: 23

24 2006 Novartis Printed in U.S.A. 10/06 CVF-OT-0064-A Printed on Recyled Paper

Executive Summary and A Vision for Health Care

Executive Summary and A Vision for Health Care N AT I O N A L C O M M U N I T Y P H A R M A C I S T S A S S O C I AT I O N Executive Summary and A Vision for Health Care The face of independent pharmacy 2006 NCPA-Pfizer Digest-In-Brief November 2006

More information

Advancing MN Pharmacy 2016 Advocacy Accomplishments & 2017 Plans

Advancing MN Pharmacy 2016 Advocacy Accomplishments & 2017 Plans Advancing MN Pharmacy 2016 Advocacy Accomplishments & 2017 Plans Jill Strykowski and Michelle Aytay MPhA Public Affairs Co Chairs, PPAJTF Session Objectives Outline the outcomes from the 2016 Legislative

More information

E-Prescribing, Formulary Searching and Exception Requests for MDwise Plans

E-Prescribing, Formulary Searching and Exception Requests for MDwise Plans E-Prescribing, Formulary Searching and Exception Requests for MDwise Plans E-Prescribing Together with its pharmacy benefits managers (PBMs), MedImpact and PerformRx, MDwise provides physicians and other

More information

Confronting the Challenges of Rare Disease:

Confronting the Challenges of Rare Disease: Confronting the Challenges of Rare Disease: SOLUTIONS ACROSS THE ENTIRE PRODUCT LIFE CYCLE The Orphan Drug Act of 1983 brought increased awareness to the need for new treatments for rare disease patients

More information

Underlying principles of the CVS Caremark Formulary Development and Management Process include the following:

Underlying principles of the CVS Caremark Formulary Development and Management Process include the following: Formulary Development and Management at CVS Caremark Development and management of drug formularies is an integral component in the pharmacy benefit management (PBM) services CVS Caremark provides to health

More information

Chapter 3 Products, Networks, and Payment Unit 4: Pharmacy and Formulary

Chapter 3 Products, Networks, and Payment Unit 4: Pharmacy and Formulary Chapter 3 Products, Networks, and Payment Unit 4: Pharmacy and Formulary In This Unit Topic See Page Unit 4: Pharmacy and Formulary Pharmaceutical Overview 2 Pharmaceutical 3 Drug 4 NOTE: This section

More information

Expanding Your Pharmacist Team

Expanding Your Pharmacist Team CALIFORNIA QUALITY COLLABORATIVE CHANGE PACKAGE Expanding Your Pharmacist Team Improving Medication Adherence and Beyond August 2017 TABLE OF CONTENTS Introduction and Purpose 1 The CQC Approach to Addressing

More information

Is your PBM working for you, or are you working for your PBM?

Is your PBM working for you, or are you working for your PBM? Is your PBM working for you, or are you working for your PBM? A SOLUTION FOR HOSPICE PHARMACY PRICING: ACHIEVING UP TO 25% - 50% IN COST REDUCTION Introduction One business dictionary defines transparency

More information

We Simplify Medication Management

We Simplify Medication Management The Dose We Simplify Medication Management November 2016 Moving Forward with Marketing Wow, hello November! The air is cooler and leaves are beginning to fall. As we wrap up the current year and look

More information

Interoperability is Happening Now

Interoperability is Happening Now Interoperability is Happening Now Nick Knowlton and Tammy Ordoyne-Vial Brightree and Ochsner HME Interoperability - Better Business, Better Outcomes Shifts in the Healthcare Ecosystem impact our HME Space

More information

TKG Health Systems Advisory Panel Meeting. Healthcare in 2017: Trends & Hot Topics. Tuesday, March 24 th, 2017 Gaylord Texan Resort, Grapevine, TX

TKG Health Systems Advisory Panel Meeting. Healthcare in 2017: Trends & Hot Topics. Tuesday, March 24 th, 2017 Gaylord Texan Resort, Grapevine, TX TKG Health Systems Advisory Panel Meeting Healthcare in 2017: Trends & Hot Topics Tuesday, March 24 th, 2017 Gaylord Texan Resort, Grapevine, TX Executive Summary Key Trends The transition to value-based

More information

Prescription for Healthy Communities: CARRYING OUT SUCCESSFUL MEDICATION MANAGEMENT SERVICES IN COMMUNITY PHARMACIES

Prescription for Healthy Communities: CARRYING OUT SUCCESSFUL MEDICATION MANAGEMENT SERVICES IN COMMUNITY PHARMACIES Prescription for Healthy Communities: CARRYING OUT SUCCESSFUL MEDICATION MANAGEMENT SERVICES IN COMMUNITY PHARMACIES Deborah Pestka, PharmD Caitlin Frail, PharmD, MS, BCACP Laura Palombi, PharmD, MPH,

More information

Pharmacy Medicine Use Review What s it all about?

Pharmacy Medicine Use Review What s it all about? Pharmacy Medicine Use Review What s it all about? 1. What is it? 1.1 Medicine use Review has been introduced under the Advanced Services tier of the New Pharmacy Contract in England & Wales. The aim of

More information

The Impact of CPOE and CDS on the Medication Use Process and Pharmacist Workflow

The Impact of CPOE and CDS on the Medication Use Process and Pharmacist Workflow The Impact of CPOE and CDS on the Medication Use Process and Pharmacist Workflow Conflict of Interest Disclosure The speaker has no real or apparent conflicts of interest to report. Anne M. Bobb, R.Ph.,

More information

IMPROVED PATIENT OUTCOMES AND FINANCIAL PERFORMANCE THE VALUE OF INTEGRATED OUTSOURCED SERVICES SUPPORTING RARE DISEASE PHARMACEUTICAL COMPANIES.

IMPROVED PATIENT OUTCOMES AND FINANCIAL PERFORMANCE THE VALUE OF INTEGRATED OUTSOURCED SERVICES SUPPORTING RARE DISEASE PHARMACEUTICAL COMPANIES. IMPROVED PATIENT OUTCOMES AND FINANCIAL PERFORMANCE THE VALUE OF INTEGRATED OUTSOURCED SERVICES SUPPORTING RARE DISEASE PHARMACEUTICAL COMPANIES. By 2020, the global cost of orphan drugs is expected to

More information

Bringing the Clinical Mindset to the Retail Pharmacist

Bringing the Clinical Mindset to the Retail Pharmacist Bringing the Clinical Mindset to the Retail Pharmacist Sarah Griffin, Pharm.D. Harding University College of Pharmacy White County Medical Center Objectives Describe challenging situations faced by pharmacists

More information

2017 Provider Satisfaction Improvement Goals

2017 Provider Satisfaction Improvement Goals 2017 Provider Satisfaction Improvement Goals Provider Relations Expand Network Health s competitive advantage in the areas of provider relations, satisfaction and loyalty Communicate 2016 Provider Satisfaction

More information

5 Key Factors to Consider when Selecting a Specialty Pharmacy. A Healthcare Provider s Guide

5 Key Factors to Consider when Selecting a Specialty Pharmacy. A Healthcare Provider s Guide 5 Key Factors to Consider when Selecting a Specialty Pharmacy A Healthcare Provider s Guide Today, an estimated 133 million Americans nearly half of the population suffer from at least one chronic illness.

More information

10 Things to Consider When Choosing a Home Care Agency

10 Things to Consider When Choosing a Home Care Agency 10 Things to Consider When Choosing a Home Care Agency Introduction Diminishing health and frailty are not popular topics of conversation for obvious reasons. But then these are not areas of life we can

More information

This section of the program, entitled Current Practices and Approaches to Treatment in Hemophilia: Case Studies, will provide case studies followed

This section of the program, entitled Current Practices and Approaches to Treatment in Hemophilia: Case Studies, will provide case studies followed Welcome to the continuing education activity entitled Challenges and Opportunities for Managing Hemophilia. We are pleased to provide you with what we hope will be an informative and meaningful program.

More information

Bridging the Gap: A Managed Care Payor Perspective. Chris Chan, PharmD Sr Director, Pharmaceutical Services Inland Empire Health Plan June 28, 2014

Bridging the Gap: A Managed Care Payor Perspective. Chris Chan, PharmD Sr Director, Pharmaceutical Services Inland Empire Health Plan June 28, 2014 Bridging the Gap: A Managed Care Payor Perspective Chris Chan, PharmD Sr Director, Pharmaceutical Services Inland Empire Health Plan June 28, 2014 Overview Pharmacy Industry: past, present, future Gaps

More information

PBM SOLUTIONS FOR PATIENTS AND PAYERS

PBM SOLUTIONS FOR PATIENTS AND PAYERS PBM SOLUTIONS FOR PATIENTS AND PAYERS Reducing Prescription Drug Costs Designing Solutions for Employers, Unions, and Government Programs Delivering High Patient Satisfaction and Improved Outcomes Improving

More information

New Alignments in Data-Driven Care Coordination & Access for Specialty Products: Insights from the DIMENSIONS Report

New Alignments in Data-Driven Care Coordination & Access for Specialty Products: Insights from the DIMENSIONS Report New Alignments in Data-Driven Care Coordination & Access for Specialty Products: Insights from the DIMENSIONS Report Our Objectives By the end of the session, participants will understand: Evolving demands

More information

Executive Summary: Davies Ambulatory Award Community Health Organization (CHO)

Executive Summary: Davies Ambulatory Award Community Health Organization (CHO) Davies Ambulatory Award Community Health Organization (CHO) Name of Applicant Organization: Community Health Centers, Inc. Organization s Address: 110 S. Woodland St. Winter Garden, Florida 34787 Submitter

More information

From Free Drug to Paid Prescriptions: PATIENT ASSISTANCE STRATEGIES TO ENSURE ROI. by Jan Nielsen, Division President, SonexusHealth

From Free Drug to Paid Prescriptions: PATIENT ASSISTANCE STRATEGIES TO ENSURE ROI. by Jan Nielsen, Division President, SonexusHealth From Free Drug to Paid Prescriptions: PATIENT ASSISTANCE STRATEGIES TO ENSURE ROI by Jan Nielsen, Division President, SonexusHealth The Role of Patient Assistance Programs Healthcare affordability is reaching

More information

Across the oncology landscape, a confluence of factors is creating new challenges to product access, optimized clinical outcomes and commercial

Across the oncology landscape, a confluence of factors is creating new challenges to product access, optimized clinical outcomes and commercial Across the oncology landscape, a confluence of factors is creating new challenges to product access, optimized clinical outcomes and commercial success. AmerisourceBergen explores those factors and trends

More information

December 12, [Submitted online at:

December 12, [Submitted online at: Centers for Medicare and Medicaid Services Department of Health and Human Services Attention: CMS-4157-P Room C4-26-05 7500 Security Boulevard Baltimore, MD 21244-1850 [Submitted online at: www.regulations.gov]

More information

Hospital Readmissions Survival Guide

Hospital Readmissions Survival Guide WHITE PAPER Hospital Readmissions Survival Guide The Long-Term Care Provider s Ultimate Survival Guide to Incorporating INTERACT into Health Information Technology (HIT) March 2017 In this survival guide,

More information

FAQ: Preferred pharmacy supplier changes for Specialty and Mail order medications

FAQ: Preferred pharmacy supplier changes for Specialty and Mail order medications FAQ: Preferred pharmacy supplier changes for Specialty and Mail order medications Table of Contents BACKGROUND... 2 OVERALL TALKING POINTS... 2 GENERAL FAQ... 3 SPECIALTY MEDICATIONS... 5 MAIL ORDER...

More information

Post-Test/ Evaluation

Post-Test/ Evaluation / Evaluation Outcomes Personal Pharmacist Training Program To obtain ACPE credit, select the electronic /Evaluation link from the training program Main Menu. Completion of this manual test does not award

More information

Statement Of. The National Association of Chain Drug Stores. For. U.S. House of Representatives Committee on Ways and Means Subcommittee on Health

Statement Of. The National Association of Chain Drug Stores. For. U.S. House of Representatives Committee on Ways and Means Subcommittee on Health Statement Of The National Association of Chain Drug Stores For U.S. House of Representatives Committee on Ways and Means Subcommittee on Health Hearing on: The President s and Other Bipartisan Proposals

More information

Issue Brief. E-Prescribing in California: Why Aren t We There Yet? Introduction. Current Status of E-Prescribing in California

Issue Brief. E-Prescribing in California: Why Aren t We There Yet? Introduction. Current Status of E-Prescribing in California E-Prescribing in California: Why Aren t We There Yet? Introduction Electronic prescribing (e-prescribing) refers to the computer-based generation of a prescription, electronic transmission of the initial

More information

Evaluation of Pharmacy Delivery Models

Evaluation of Pharmacy Delivery Models Evaluation of Pharmacy Delivery Models As Required By House Bill 1, 84th Legislature, Regular Session, 2015 (Article II, Health and Human Services Commission, Rider 83) Health and Human Services Commission

More information

Long Term Care Pharmacy

Long Term Care Pharmacy Long Term Care Pharmacy Medication Reconciliation in The Electronic Age Courtney Doherty Oland R.Ph, MBA President The LTC setting is currently under enormous transformation silver tsunami - greater demand/

More information

Improving Clinical Outcomes

Improving Clinical Outcomes Improving clinical outcomes and reducing health care costs under the Affordable Care Act - are enhanced medication management strategies part of the solution? Sandra L. Baldinger, Pharm.D., M.S. Kenneth

More information

1. When will physicians who are not "meaningful" EHR users start to see a reduction in payments?

1. When will physicians who are not meaningful EHR users start to see a reduction in payments? CPPM Chapter 7 Review Questions 1. When will physicians who are not "meaningful" EHR users start to see a reduction in payments? a. January 1, 2013 b. January 1, 2015 c. January 1, 2016 d. January 1, 2017

More information

Researched Medicines Industry Association of New Zealand Incorporated. Submission on Pharmacist Prescribers

Researched Medicines Industry Association of New Zealand Incorporated. Submission on Pharmacist Prescribers Researched Medicines Industry Association of New Zealand Incorporated Submission on Pharmacist Prescribers July 2010 Researched Medicines Industry Association of New Zealand Incorporated Level 8, 86-90

More information

I want to participate in the CMTM pharmacy network. How do I get started?

I want to participate in the CMTM pharmacy network. How do I get started? Pharmacy FAQ for CMTM 07-18-06 What is Community MTM (CMTM)? Community MTM is a Web-based communications service that allows pharmacists to conduct, document, and bill for a variety of sponsors patient

More information

Hospital Readmissions

Hospital Readmissions Hospital Readmissions The Long-Term Care Provider s Ultimate Survival Guide to Incorporating INTERACT TM Into Health Information Technology (HIT) In this survival guide, we ll give you the tips you need

More information

Pharmacy Quality Measures. Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2013

Pharmacy Quality Measures. Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2013 Pharmacy Quality Measures Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2013 Objectives Explain the purpose of quality measures and how they are developed Identify quality

More information

HEALTHY EMPLOYEES HEALTHY EMPLOYEE BENEFIT PLAN

HEALTHY EMPLOYEES HEALTHY EMPLOYEE BENEFIT PLAN HEALTHY EMPLOYEES HEALTHY EMPLOYEE BENEFIT PLAN At a point in time when many employers are forced to cut benefits healthcare costs are increasing at 3 to 4 times the rate of inflation access to quality

More information

Become a trusted advisor to your patients

Become a trusted advisor to your patients Become a trusted advisor to your patients Kizer Pharmacy s four steps to success during Medicare Open Enrollment Pharmacy best practice Kizer Pharmacy Six out of ten Medicare patients don t review their

More information

Pharmacovigilance & Managed Care Pharmacy. Issues for Medication Safety in Korea

Pharmacovigilance & Managed Care Pharmacy. Issues for Medication Safety in Korea Pharmacovigilance and Managed Care Pharmacy Issues for Medication Safety in Korea Hyun Taek Shin, Pharm.D. Professor, College of Pharmacy Sookmyung University & President, Korean Academy of Managed Care

More information

LDL Control Causal Tree

LDL Control Causal Tree LDL Control Causal Tree This material was prepared by HealthInsight, the Medicare Quality Innovation Network Quality Improvement Organization for Nevada, New Mexico, Oregon Utah, under contract with the

More information

COLLABORATING FOR VALUE. A Winning Strategy for Health Plans and Providers in a Shared Risk Environment

COLLABORATING FOR VALUE. A Winning Strategy for Health Plans and Providers in a Shared Risk Environment COLLABORATING FOR VALUE A Winning Strategy for Health Plans and Providers in a Shared Risk Environment Collaborating for Value Executive Summary The shared-risk payment models central to health reform

More information

Low-Cost, Low-Administrative Burden Ways to Better Integrate Care for Medicare-Medicaid Enrollees

Low-Cost, Low-Administrative Burden Ways to Better Integrate Care for Medicare-Medicaid Enrollees TECHNICAL ASSISTANCE BRIEF J UNE 2 0 1 2 Low-Cost, Low-Administrative Burden Ways to Better Integrate Care for Medicare-Medicaid Enrollees I ndividuals eligible for both Medicare and Medicaid (Medicare-Medicaid

More information

Joint Medicaid Oversight Committee Medicaid Behavioral Health Re-Design Panel Testimony

Joint Medicaid Oversight Committee Medicaid Behavioral Health Re-Design Panel Testimony Joint Medicaid Oversight Committee Medicaid Behavioral Health Re-Design Panel Testimony Jennifer Riha, BAS, MAC, Vice President of Operations A Renewed Mind Behavioral Health September 22, 2016 Senator

More information

Position Statement on Prescription Drug Shortages in Canada

Position Statement on Prescription Drug Shortages in Canada CMA POLICY Position Statement on Prescription Drug Shortages in Canada The escalation in shortages of prescription drugs in the past few years and the ongoing disruptions to supply experienced in Canada

More information

Market With Innovation

Market With Innovation Leading The Specialty Market With Innovation Alan Lotvin, M.D. Executive Vice President, CVS/specialty Agenda Specialty Market Overview Performance Highlights Reinventing Specialty Pharmacy Well Positioned

More information

CBI 14 th Annual Specialty Therapies: Site of Care Optimization and Data Driven Specialty

CBI 14 th Annual Specialty Therapies: Site of Care Optimization and Data Driven Specialty CBI 14 th Annual Specialty Therapies: Site of Care Optimization and Data Driven Specialty Avalere Health An Inovalon Company January, 2017 High Specialty Drug Spend Fuels Interest in Management Strategies

More information

Exclusively for Health Advocate Members. All-in-1 Benefit. Benefits Gateway Personal Dashboard Healthcare Help Wellness Support EAP+Work/Life

Exclusively for Health Advocate Members. All-in-1 Benefit. Benefits Gateway Personal Dashboard Healthcare Help Wellness Support EAP+Work/Life Exclusively for Health Advocate Members All-in-1 Benefit Benefits Gateway Benefits Gateway Connect to the right benefit Welcome to HealthAdvocate Health Advocate is a service provided by your employer

More information

Medication Reconciliation

Medication Reconciliation Medication Reconciliation Where are we now? Angie Powell, PharmD Director of Pharmacy Baxter Regional Medical Center Disclosures I, Angie Powell, have no relevant financial relationships to disclose. Learning

More information

NCL MEDICATION ADHERENCE CAMPAIGN FREQUENTLY ASKED QUESTIONS 2013

NCL MEDICATION ADHERENCE CAMPAIGN FREQUENTLY ASKED QUESTIONS 2013 NCL MEDICATION ADHERENCE CAMPAIGN FREQUENTLY ASKED QUESTIONS 2013 1. WHAT EXACTLY IS MEDICATION ADHERENCE? Adhering to medication means taking the medication as directed by a health care professional-

More information

Provider Satisfaction Survey

Provider Satisfaction Survey Aetna Better Health of Michigan 1333 Gratiot Avenue, Suite 400 Detroit, MI 48207 1-866-316-3784 Provider Satisfaction Survey 1. How many years have you been in this practice? a. Less than 5 years b. 5-15

More information

Pharmacy Management. 450 Pharmacy Management Positions

Pharmacy Management. 450 Pharmacy Management Positions 450 Pharmacy Management Positions Pharmacy Management Disposition of Illicit Substances (1522) To advocate that healthcare organizations be required to develop procedures for the disposition of illicit

More information

Long Term Care Group Services Organizations Not Just for Nursing Home Providers Anymore

Long Term Care Group Services Organizations Not Just for Nursing Home Providers Anymore Long Term Care Group Services Organizations Not Just for Nursing Home Providers Anymore Presented by: Denny Sherrill, Vice President, GeriMed John Schutte, President, GeriMed 2:15 p.m. - 3:45 p.m., Tuesday,

More information

NCPDP Work Group 11 Task Group: RxFill White Paper on Implementation Issues

NCPDP Work Group 11 Task Group: RxFill White Paper on Implementation Issues NCPDP Work Group 11 Task Group: RxFill White Paper on Implementation Issues Purpose: To highlight and provide a general overview of issues that arise in the implementation of RxFill transactions. The discussion

More information

Clinical Management of patients: The case for Comprehensive Medication Therapy Management Services

Clinical Management of patients: The case for Comprehensive Medication Therapy Management Services Clinical Management of patients: The case for Comprehensive Medication Therapy Management Services Professor Djenane Ramalho de Oliveira, PhD Director, Centro de Estudos em Atenção Farmacêutica (CEAF)

More information

National Survey on Consumers Experiences With Patient Safety and Quality Information

National Survey on Consumers Experiences With Patient Safety and Quality Information Summary and Chartpack The Kaiser Family Foundation/Agency for Healthcare Research and Quality/Harvard School of Public Health National Survey on Consumers Experiences With Patient Safety and Quality Information

More information

ENHANCING PRESCRIBER RELATIONSHIPS: MAKING IT A WIN-WIN JULY 12, :00 5:00 PM

ENHANCING PRESCRIBER RELATIONSHIPS: MAKING IT A WIN-WIN JULY 12, :00 5:00 PM ENHANCING PRESCRIBER RELATIONSHIPS: MAKING IT A WIN-WIN JULY 12, 2017 3:00 5:00 PM ACPE UAN: 0107-9999-17-105-L04-P 0.2 CEU/2.0 hr Activity Type: Knowledge-Based Learning Objectives for Pharmacists: Upon

More information

Drivers of HCAHPS Performance from the Front Lines of Healthcare

Drivers of HCAHPS Performance from the Front Lines of Healthcare Drivers of HCAHPS Performance from the Front Lines of Healthcare White Paper by Baptist Leadership Group 2011 Organizations that are successful with the HCAHPS survey are highly focused on engaging their

More information

16 Pharmacy Technician Julie Yandt.

16 Pharmacy Technician Julie Yandt. BARRIE AREA HOSPITAL TAKES LEAD IN REGULATED TECHNICIANS 16 Pharmacy Technician Julie Yandt. The previous two issues of Pharmacy Connection have showcased how a community pharmacy practice (Winter 2012)

More information

Health plans for New Hampshire small businesses Available through the Health Insurance Marketplace

Health plans for New Hampshire small businesses Available through the Health Insurance Marketplace Health plans for New Hampshire small businesses Available through the Health Insurance Marketplace 1 38476NHEENABS Rev. 09/14 We can help you navigate the health care road We re here to help. In fact,

More information

Member Service Information

Member Service Information Member Service Information For your EnvisionRx pharmacy benefit & prescription mail order option Support for your pharmacy benefit Register to manage your benefit online To manage your benefits conveniently

More information

STRATEGIC PLAN

STRATEGIC PLAN 2012-2018 STRATEGIC PLAN 2012-2018 STRATEGIC PLAN (Updated April 2018) INTRODUCTION The Michigan Pharmacists Association (MPA) is a nonprofit corporation organized in 1883, incorporated under the provisions

More information

BREAKING HABITS. GETTING NEW PATIENTS TO COME TO YOU

BREAKING HABITS. GETTING NEW PATIENTS TO COME TO YOU April 13, 2018 BREAKING HABITS. GETTING NEW PATIENTS TO COME TO YOU Liz Tiefenthaler President, Pharm Fresh Disruptors and the Disrupted Kindle- Borders and other bookstores Digital cameras and smart phones-

More information

General Office and Patient Compliance Policies

General Office and Patient Compliance Policies General Office and Patient Compliance Policies Thank you for choosing Innate Wellness & Medical Center as your medical provider. We are providing you this updated information to keep you informed of our

More information

Experiential Education

Experiential Education Experiential Education Experiential Education Page 1 Experiential Education Contents Introduction to Experiential Education... 3 Experiential Education Calendar... 4 Selected ACPE Standards 2007... 5 Standard

More information

Payment: We are permitted to use and disclose your health information to receive payment for our services. For example, we may:

Payment: We are permitted to use and disclose your health information to receive payment for our services. For example, we may: Your Rx Pharmacy Notice of our privacy practices THIS NOTICE DESCRIBES HOW HEALTH INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.

More information

Conducting Family Conferences at End of Life

Conducting Family Conferences at End of Life COVENANT HEALTH ETHICS CONFERENCE 2013 Conducting Family Conferences at End of Life Meg Hagerty Social Worker, Mel Miller Hospice, Edmonton General Ingrid de Kock Palliative Care Physician, Palliative

More information

Medication Safety Action Bundle Adverse Drug Events (ADE) All High-Risk Medication Safety

Medication Safety Action Bundle Adverse Drug Events (ADE) All High-Risk Medication Safety Medication Safety Action Bundle Adverse Drug Events (ADE) All High-Risk Medication Safety Background The Institute of medicine (IOM) estimates that 1.5 million preventable Adverse Drug Events (ADE) occur

More information

PHA 6276 Syllabus Pharmacy Benefit Design & Management Course

PHA 6276 Syllabus Pharmacy Benefit Design & Management Course PHA 6276 Syllabus Pharmacy Benefit Design & Management Course Course Purpose This course teaches students the fundamental components and practical execution of managed care prescription drug benefit programs,

More information

All ACO materials are available at What are my network and plan design options?

All ACO materials are available at   What are my network and plan design options? ACO Toolkit: A Roadmap for Employers What is an ACO? Is an ACO strategy right for my company? Which ACOs are ready? All ACO materials are available at www.businessgrouphealth.org What are my network and

More information

Run Management Reports Tutorial

Run Management Reports Tutorial Run Management Reports Tutorial July 2014 Login to InstyMeds Go to the InstyMeds Web site at: http://webinstymeds.com Enter Username Enter Password Click Login button Click on Reports 2 Select the desired

More information

3/16/2017. A Tale of Two Specialty Pharmacies: Novel Models for Technician Incorporation. Objectives. What is Specialty Pharmacy?

3/16/2017. A Tale of Two Specialty Pharmacies: Novel Models for Technician Incorporation. Objectives. What is Specialty Pharmacy? A Tale of Two Specialty Pharmacies: Novel Models for Technician Incorporation Disclosures The speakers have no actual or potential conflict of interest to the content of this presentation. Renee Advincula,

More information

nhs voice: we re listening NHS client experience survey results December 2015 January 2016

nhs voice: we re listening NHS client experience survey results December 2015 January 2016 nhs voice: we re listening NHS client experience survey results December 2015 January 2016 we re listening As a leading provider of clinical healthcare in Europe, we support more than 150,000 patients

More information

specialty pharmacy: reining in costs and improving health outcomes

specialty pharmacy: reining in costs and improving health outcomes specialty pharmacy: reining in costs and improving health outcomes Overview Specialty drugs are bringing great advances in health care and dramatically improving the medical outlook for employees and covered

More information

Penn Specialty Pharmacy Program mypennpharmacy bringing the Pharmacy to Patients

Penn Specialty Pharmacy Program mypennpharmacy bringing the Pharmacy to Patients Penn Specialty Pharmacy Program mypennpharmacy bringing the Pharmacy to Patients Richard F Demers, MS, RPh, FASHP Chief Administrative Officer Ambulatory Pharmacy Services University of Pennsylvania Health

More information

Articles of Importance to Read: AmeriChoice Tennessee s Provider University. Spring 2010

Articles of Importance to Read: AmeriChoice Tennessee s Provider University. Spring 2010 Important information for physicians and other health care professionals and facilities serving AmeriChoice members Spring 2010 AmeriChoice Tennessee s Provider University AmeriChoice Tennessee s Provider

More information

Room 505A, Humphrey Building, HHS, Washington, DC January 25, 2010

Room 505A, Humphrey Building, HHS, Washington, DC January 25, 2010 Statement of the National Community Pharmacists Association to the HIT Policy Committee Information Exchange Workgroup Hearing on Successes and Challenges Related to E-Prescribing Room 505A, Humphrey Building,

More information

Patient Navigation: A Multidisciplinary Team Approach

Patient Navigation: A Multidisciplinary Team Approach Patient Navigation: A Multidisciplinary Team Approach by David Nicewonger, MHA MultiCare Health System is a community-based healthcare organization based in Tacoma, Washington, that includes four hospitals,

More information

Marketing. Pharmaceutical Industry: Marketing Positions 445

Marketing. Pharmaceutical Industry: Marketing Positions 445 Marketing Pharmaceutical Industry: Marketing Positions 445 Restricted Drug Distribution (1714) To oppose restricted drug distribution systems that (1) limit patient access to medications; (2) undermine

More information

Driving the value of health care through integration. Kaiser Permanente All Rights Reserved.

Driving the value of health care through integration. Kaiser Permanente All Rights Reserved. Driving the value of health care through integration February 13, 2012 Kaiser Permanente 2010-2011. All Rights Reserved. 1 Today s agenda How Kaiser Permanente is transforming care How we re updating our

More information

eprescribing Information to Improve Medication Adherence

eprescribing Information to Improve Medication Adherence eprescribing Information to Improve Medication Adherence April 2017 (revised) About Point-of-Care Partners Executive Summary Point-of-Care Partners (POCP) is a leading management consulting firm assisting

More information

Specialty Pharmacy: What You Need To Know. William Pong, Pharm.D., MBA

Specialty Pharmacy: What You Need To Know. William Pong, Pharm.D., MBA Specialty Pharmacy: What You Need To Know William Pong, Pharm.D., MBA DISCLOSURE I have no actual or potential conflict of interest in relation to this program/ presentation OBJECTIVEs Navigating the landscape

More information

1500 West Park Drive Suite 100 Westborough, MA (508) August 21, 2018

1500 West Park Drive Suite 100 Westborough, MA (508) August 21, 2018 1500 West Park Drive Suite 100 Westborough, MA 01581 (508) 621-7320 August 21, 2018 Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Subject: CMS-1693-P Dear Madam/Sir,

More information

ELECTIVE COMPETENCY AREAS, GOALS, AND OBJECTIVES FOR POSTGRADUATE YEAR ONE (PGY1) PHARMACY RESIDENCIES

ELECTIVE COMPETENCY AREAS, GOALS, AND OBJECTIVES FOR POSTGRADUATE YEAR ONE (PGY1) PHARMACY RESIDENCIES ELECTIVE COMPETENCY AREAS, GOALS, AND OBJECTIVES FOR POSTGRADUATE YEAR ONE (PGY1) PHARMACY RESIDENCIES Introduction The competency areas, goals, and objectives are for use with the ASHP Accreditation Standard

More information

Human Factors. Frank Federico, RPh. This presenter has nothing to disclose.

Human Factors. Frank Federico, RPh. This presenter has nothing to disclose. Human Factors Frank Federico, RPh This presenter has nothing to disclose. 25 February 2015 Culture Learning System Improvement and Measurement Transparency Continuous Learning Accountability Teamwork &

More information

As pharmacists roles expand to near provider status, new opportunities for partnerships open up for pharma. FAST FACT

As pharmacists roles expand to near provider status, new opportunities for partnerships open up for pharma. FAST FACT Published in October 2014 Copyright 2014 by PharmaLinx LLC Robin Robinson In the PHARMACY As pharmacists roles expand to near provider status, new opportunities for partnerships open up for pharma. O ver

More information

14 th May Pharmacy Voice. 4 Bloomsbury Square London WC1A 2RP T E

14 th May Pharmacy Voice. 4 Bloomsbury Square London WC1A 2RP T E Consultation response Department of Health Rebalancing Medicines Legislation and Pharmacy Regulation: draft orders under section 60 of the Health Act 1999 14 th May 2015 Pharmacy Voice 4 Bloomsbury Square

More information

Omnibus Budget Reconciliation Act of 1990 and 1993

Omnibus Budget Reconciliation Act of 1990 and 1993 Omnibus Budget Reconciliation Act of 1990 and 1993 Pantea Ghasemi, USC Pharm.D. Candidate of 2015 Sarkis Kavarian, UOP Pharm.D. Candidate of 2015 Preceptor Dr. Craig Stern Pro Pharma Pharmaceutical Consultants,

More information

Driving Business Value for Healthcare Through Unified Communications

Driving Business Value for Healthcare Through Unified Communications Driving Business Value for Healthcare Through Unified Communications Even the healthcare sector is turning to technology to take a 'connected' approach, as organizations align technology and operational

More information

managed care solutions

managed care solutions Sedgwick connects care and claims management solutions with one team operating in one system. Our multi-disciplinary team provides guidance and support to help achieve the best and fastest recovery outcome

More information

38 May June 2014 OI

38   May June 2014 OI 38 www.accc-cancer.org May June 2014 OI BY MICHAEL J. REFF, RPH, MBA Physician Dispensing Adding value to patients and the practice While oral oncolytics are serious medications prescribed to help patients

More information

Block Title: Patient Care Experience Block #: PHRM 701, 702, 703, 704 and PHRM 705, 706, and 707 (if patient care)

Block Title: Patient Care Experience Block #: PHRM 701, 702, 703, 704 and PHRM 705, 706, and 707 (if patient care) Block Coordinator & Contact Information: Credit(s) & format: Section I. Block Description & Goals Jeremy Hughes, PharmD Director for Experiential Education & Assistant Professor Office: Creighton Hall

More information

[date] Health Net s Medicare Advantage and Dual Eligible Programs Issue Write-Up Form - Instructions for Completion

[date] Health Net s Medicare Advantage and Dual Eligible Programs Issue Write-Up Form - Instructions for Completion Health Net s Medicare Advantage and Dual Eligible Programs Issue Write-Up Form - Instructions for Completion This process is not related to and is separate from any provider appeals processes. Consider

More information

Pharmaceutical Services Report to Joint Conference Committee September 2010

Pharmaceutical Services Report to Joint Conference Committee September 2010 Pharmaceutical Services Report to Joint Conference Committee September 21 Background: Pharmaceutical Services staffing has increased by 31 FTE from 26 due to program changes and to comply with regulatory

More information

California s Chronically Ill: Coping with Rising Health Care Costs

California s Chronically Ill: Coping with Rising Health Care Costs California s Chronically Ill: 2005 Introduction As health plan coverage continues to move towards member cost sharing, particular concern has been raised about the impact of these changes on those with

More information

Improving the Patient Experience Through Pharmacy

Improving the Patient Experience Through Pharmacy Rick Burnett Chief Operating Officer Kenneth Maxik Director, Patient Safety & Pharmacy Compliance Improving the Patient Experience Through Pharmacy August 19, 2015 Speakers Rick Burnett, PharmD, FACHE

More information

Oncology Pharmacy Services

Oncology Pharmacy Services Oncology Pharmacy Services Your partner in patient-centered care Supporting you and your patients You want to focus on patient care, not paperwork. So you need an oncology pharmacy that does more than

More information